A detailed history of Raymond James & Associates transactions in Black Rock Health Sciences Trust stock. As of the latest transaction made, Raymond James & Associates holds 45,502 shares of BME stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,502
Previous 44,877 1.39%
Holding current value
$1.78 Million
Previous $1.83 Million 4.04%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$39.94 - $42.41 $24,962 - $26,506
625 Added 1.39%
45,502 $1.91 Million
Q2 2024

Jul 19, 2024

BUY
$38.45 - $40.88 $112,696 - $119,819
2,931 Added 6.99%
44,877 $1.83 Million
Q1 2024

Apr 22, 2024

BUY
$40.6 - $42.71 $51,683 - $54,369
1,273 Added 3.13%
41,946 $1.74 Million
Q4 2023

Jan 16, 2024

BUY
$35.53 - $40.46 $48,853 - $55,632
1,375 Added 3.5%
40,673 $1.65 Million
Q3 2023

Oct 24, 2023

BUY
$38.98 - $40.9 $26,779 - $28,098
687 Added 1.78%
39,298 $1.54 Million
Q2 2023

Jul 25, 2023

BUY
$39.55 - $42.93 $37,770 - $40,998
955 Added 2.54%
38,611 $1.57 Million
Q1 2023

Apr 14, 2023

BUY
$39.34 - $43.68 $30,606 - $33,983
778 Added 2.11%
37,656 $1.58 Million
Q4 2022

Feb 08, 2023

BUY
$38.85 - $44.88 $8,896 - $10,277
229 Added 0.62%
36,878 $1.61 Million
Q3 2022

Oct 25, 2022

BUY
$38.27 - $44.96 $6,773 - $7,957
177 Added 0.49%
36,649 $1.42 Million
Q2 2022

Aug 12, 2022

SELL
$39.97 - $46.86 $2,717 - $3,186
-68 Reduced 0.19%
36,472 $1.55 Million
Q1 2022

May 11, 2022

BUY
$41.57 - $48.2 $50,174 - $58,177
1,207 Added 3.42%
36,540 $1.66 Million
Q4 2021

Feb 08, 2022

BUY
$45.5 - $48.62 $406,861 - $434,760
8,942 Added 33.88%
35,333 $1.71 Million
Q3 2021

Nov 02, 2021

BUY
$47.27 - $49.44 $38,997 - $40,788
825 Added 3.23%
26,391 $1.26 Million
Q2 2021

Aug 11, 2021

BUY
$46.22 - $49.63 $164,496 - $176,633
3,559 Added 16.17%
25,566 $1.24 Million
Q1 2021

May 14, 2021

BUY
$44.61 - $50.31 $214,484 - $241,890
4,808 Added 27.96%
22,007 $1.02 Million
Q4 2020

Feb 12, 2021

SELL
$41.7 - $48.67 $18,723 - $21,852
-449 Reduced 2.54%
17,199 $818,000
Q3 2020

Nov 04, 2020

BUY
$40.57 - $44.0 $11,603 - $12,584
286 Added 1.65%
17,648 $756,000
Q2 2020

Jul 28, 2020

SELL
$33.63 - $43.1 $132,165 - $169,383
-3,930 Reduced 18.46%
17,362 $708,000
Q1 2020

Apr 21, 2020

BUY
$27.7 - $43.99 $32,907 - $52,260
1,188 Added 5.91%
21,292 $768,000
Q4 2019

Feb 12, 2020

BUY
$36.74 - $42.5 $43,242 - $50,022
1,177 Added 6.22%
20,104 $854,000
Q3 2019

Nov 07, 2019

BUY
$37.6 - $39.3 $26,470 - $27,667
704 Added 3.86%
18,927 $724,000
Q2 2019

Aug 06, 2019

SELL
$36.0 - $40.32 $51,300 - $57,456
-1,425 Reduced 7.25%
18,223 $709,000
Q1 2019

May 06, 2019

SELL
$36.43 - $41.0 $126,703 - $142,598
-3,478 Reduced 15.04%
19,648 $782,000
Q4 2018

Feb 11, 2019

BUY
$32.3 - $43.99 $8,753 - $11,921
271 Added 1.19%
23,126 $843,000
Q3 2018

Nov 14, 2018

BUY
$38.7 - $42.67 $349,577 - $385,438
9,033 Added 65.35%
22,855 $972,000
Q2 2018

Aug 14, 2018

BUY
$33.82 - $39.42 $10,146 - $11,826
300 Added 2.22%
13,822 $533,000
Q1 2018

May 14, 2018

SELL
$33.42 - $37.23 $21,723 - $24,199
-650 Reduced 4.59%
13,522 $473,000
Q3 2017

Nov 13, 2017

BUY
$34.86 - $37.3 $26,249 - $28,086
753 Added 5.61%
14,172 $517,000
Q2 2017

Aug 14, 2017

BUY
N/A
13,419
13,419 $492,000

Others Institutions Holding BME

About BlackRock Health Sciences Trust


  • Ticker BME
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in r...
More about BME
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.